Abstract
Purpose
To investigate the clinical features and treatment outcomes of patients with choroidal tuberculoma.
Methods
In this retrospective, observational case series, the medical records of five patients with choroidal tuberculoma who were followed up at a university hospital for at least 6 months were analyzed.
Results
Of five patients, one was male and four were female. The overall mean age was 38.0 ± 9.4 years (mean follow-up: 41.2 ± 33.8 months). Tuberculin skin test was performed in three patients, and it was positive in two of them. Interferon-gamma assay was performed in two patients and was positive in all two. Three patients had systemic tuberculosis involving the lung or other organs. Five patients were treated with antitubercular therapy for a period of 9.6 ± 8.6 months. Systemic corticosteroid treatment was performed in 3 patients, with a period of 3.5 ± 0.7 months. One patient with a recurrent vascularized tuberculoma was successfully treated with single intravitreal bevacizumab injection.
Conclusion
Choroidal tuberculoma can develop without evidence of systemic tuberculosis and can recur despite antitubercular treatment. High index of suspicion is important in early detection, and management of choroidal tuberculoma. In cases of suspected choroidal tuberculoma, positive results on immunological tests would be sufficient to initiate antitubercular therapy even if radiological evidence of systemic tuberculosis is not found. Antitubercular therapy combined with systemic corticosteroids provided favorable results. Intravitreal injection of anti-vascular endothelial growth factor may be considered for highly vascularized choroidal tuberculoma.
Similar content being viewed by others
Availability of data and materials
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
None.
References
Dogra M, Singh R, Agarwal A, Sharma A, Singh SR, Gautam N, Yangzes S, Samanta R, Sharma M, Aggarwal K, Sharma A, Sharma K, Bansal R, Gupta A, Gupta V (2017) Epidemiology of uveitis in a tertiary-care referral institute in North India. Ocul Immunol Inflamm 25(sup1):S46-s53. https://doi.org/10.1080/09273948.2016.1255761
Nguyen M, Siak J, Chee SP, Diem VQH (2017) The spectrum of uveitis in Southern Vietnam. Ocul Immunol Inflamm 25(sup1):S100-s106. https://doi.org/10.1080/09273948.2016.1231826
Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, Androudi S (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26(1):2–16. https://doi.org/10.1080/09273948.2016.1196713
Gupta V, Shoughy SS, Mahajan S, Khairallah M, Rosenbaum JT, Curi A, Tabbara KF (2015) Clinics of ocular tuberculosis. Ocul Immunol Inflamm 23(1):14–24. https://doi.org/10.3109/09273948.2014.986582
Annamalai R, Biswas J (2015) Bilateral choroidal tuberculoma in miliary tuberculosis - report of a case. J Ophthalmic Inflamm Infect 5:4. https://doi.org/10.1186/s12348-014-0032-x
Arej N, Fadlallah A, Chelala E (2016) Choroidal tuberculoma as a presenting sign of tuberculosis. Int Med Case Rep J 9:365–368. https://doi.org/10.2147/imcrj.S119703
Agrawal R, Gunasekeran DV, Agarwal A, Carreno E, Aggarwal K, Gupta B, Raje D, Murthy SI, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, Gonzalez-Lopez JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Lord J, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Kempen J, Cunningham ET, Rousselot A, Nguyen QD, Pavesio C, Gupta V (2018) The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm:1–11. https://doi.org/10.1080/09273948.2018.1489061
Agarwal A, Aggarwal K, Gupta V (2019) Infectious uveitis: an Asian perspective Eye (Lond) 33(1):50–65. https://doi.org/10.1038/s41433-018-0224-y
Zhang M, Zhang J, Liu Y (2012) Clinical presentations and therapeutic effect of presumed choroidal tuberculosis. Retina 32(4):805–813. https://doi.org/10.1097/IAE.0b013e3182215b5e
Tayanc E, Akova Y, Yilmaz G (2004) Indocyanine green angiography in ocular tuberculosis. Ocul Immunol Inflamm 12(4):317–322. https://doi.org/10.1080/092739490500336
Song JH, Koreishi AF, Goldstein DA (2019) Tuberculous uveitis presenting with a bullous exudative retinal detachment: a case report and systematic literature review. Ocul Immunol Inflamm 27(6):998–1009. https://doi.org/10.1080/09273948.2018.1485958
Bansal R, Beke N, Sharma A, Gupta A (2013) Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma. BMJ Case Rep 2013. https://doi.org/10.1136/bcr-2013-200255
Jain S, Bajgai P, Tigari B, Sharma K, Sharma A, Gupta V, Singh R (2016) Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma. J Ophthalmic Inflamm Infect 6(1):42. https://doi.org/10.1186/s12348-016-0112-1
Oehlers SH, Cronan MR, Scott NR, Thomas MI, Okuda KS, Walton EM, Beerman RW, Crosier PS, Tobin DM (2015) Interception of host angiogenic signalling limits mycobacterial growth. Nature 517(7536):612–615. https://doi.org/10.1038/nature13967
De Keyser E, De Keyser F, De Baets F (2014) Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta Clin Belg 69(5):358–366. https://doi.org/10.1179/2295333714y.0000000043
Haas MK, Belknap RW (2019) Diagnostic tests for latent tuberculosis infection. Clin Chest Med 40(4):829–837. https://doi.org/10.1016/j.ccm.2019.07.007
Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, Metcalfe JZ, Cattamanchi A, Dowdy DW, Dheda K, Banaei N (2014) Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 27(1):3–20. https://doi.org/10.1128/cmr.00034-13
Jeroudi A, Yeh S (2014) Diagnostic vitrectomy for infectious uveitis. Int Ophthalmol Clin 54(2):173–197. https://doi.org/10.1097/iio.0000000000000017
Ortega-Larrocea G, Bobadilla-del-Valle M, Ponce-de-Leon A, Sifuentes-Osornio J (2003) Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. Arch Med Res 34(2):116–119. https://doi.org/10.1016/s0188-4409(02)00467-8
Yeh S, Sen HN, Colyer M, Zapor M, Wroblewski K (2012) Update on ocular tuberculosis. Curr Opin Ophthalmol 23(6):551–556. https://doi.org/10.1097/ICU.0b013e328358ba01
Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, Murthy SL, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreno E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, Gonzalez-Lopez JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham E, Nguyen QD, Pavesio C, Gupta V (2019) The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm 27(3):465–473. https://doi.org/10.1080/09273948.2017.1406529
Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V (2020) Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology. https://doi.org/10.1016/j.ophtha.2020.01.008
Gupta V, Gupta A, Sachdeva N, Arora S, Bambery P (2006) Successful management of tubercular subretinal granulomas. Ocul Immunol Inflamm 14(1):35–40. https://doi.org/10.1080/09273940500269939
Dorhoi A, Reece ST, Kaufmann SH (2011) For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol Rev 240(1):235–251. https://doi.org/10.1111/j.1600-065X.2010.00994.x
Jain S, Agarwal A, Gupta V (2019) Resolution of large choroidal tuberculoma following monotherapy with intravitreal ranibizumab. Ocul Immunol Inflamm:1–4. https://doi.org/10.1080/09273948.2019.1582786
Babu K, Murthy PR, Murthy KR (2010) Intravitreal bevacizumab as an adjunct in a patient with presumed vascularised choroidal tubercular granuloma. Eye (Lond) 24(2):397–399. https://doi.org/10.1038/eye.2009.83
Tripathy K (2017) Choroidal neovascular membrane in intraocular tuberculosis. GMS Ophthalmol Cases 7:Doc24. https://doi.org/10.3205/oc000075
Atmaca L, Yalcindag FN, Ciledag A (2012) Choroidal tuberculoma in a patient with ocular Behcet disease. Int Ophthalmol 32(1):93–96. https://doi.org/10.1007/s10792-012-9526-4
Funding
This study was supported by a faculty research grant from Yonsei University College of Medicine [grant number 2017–32-0037]. This research was supported by the Korean Association of Retinal Degeneration.
Author information
Authors and Affiliations
Contributions
DHL, JL, and MK developed the study concept and design, as well as analyzed and interpreted the data. DHL and HC participated in data collection. DHL and MK drafted the manuscript. DHL, JL, EYC, SCL, and MK critically revised the manuscript. SCL and MK supervised the study. All the authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was conducted in accordance with the tenets of the Declaration of Helsinki, and was approved by the Institutional Review Board of the Gangnam Severance Hospital (IRB approval number: 3–2020-0094).
Consent to participate
The informed consent was waived.
Consent for publication
The informed consent was waived.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, D.H., Cho, H., Lee, J. et al. Clinical features and long-term treatment outcomes in choroidal tuberculoma. Graefes Arch Clin Exp Ophthalmol 260, 1641–1650 (2022). https://doi.org/10.1007/s00417-021-05474-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05474-9